{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:42:40Z","timestamp":1792222960470,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.seizure.2026.10.005","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:29:33Z","timestamp":1791473373000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acetazolamide in drug-resistant epilepsy: a systematic review with meta-analysis"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3659-6478","authenticated-orcid":false,"given":"Amar A.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9223-0682","authenticated-orcid":false,"given":"Shanjali Arulmozhi","family":"Arasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8090-9834","authenticated-orcid":false,"given":"Bruce R.","family":"Lasker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.seizure.2026.10.005_bib0001","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.10.005_bib0002","series-title":"Epilepsy","year":"2023"},{"issue":"5","key":"10.1016\/j.seizure.2026.10.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213372","article-title":"Influence of risk factor combinations on incidence rates of SUDEP: a population-based study","volume":"104","author":"Tomson","year":"2025","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.seizure.2026.10.005_bib0004","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.0000000000003685","article-title":"Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"88","author":"Harden","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2026.10.005_bib0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2026.10.005_bib0006","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.10.005_bib0007","series-title":"Diamox (acetazolamide) tablets and sequels [package insert]","year":"2024"},{"key":"10.1016\/j.seizure.2026.10.005_bib0008","series-title":"StatPearls","article-title":"Acetazolamide","author":"Farzam","year":"2023"},{"issue":"3","key":"10.1016\/j.seizure.2026.10.005_bib0009","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/epi4.12619","article-title":"Acetazolamide: old drug, new evidence?","volume":"7","author":"Shukralla","year":"2022","journal-title":"Epilepsia Open"},{"issue":"5","key":"10.1016\/j.seizure.2026.10.005_bib0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1528-1157.2002.32601.x","article-title":"Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons","volume":"43","author":"Leniger","year":"2002","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2026.10.005_bib0011","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1523\/JNEUROSCI.3836-13.2014","article-title":"Intracellular bicarbonate regulates action potential generation via KCNQ channel modulation","volume":"34","author":"Jones","year":"2014","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.seizure.2026.10.005_bib0012","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"L\u00f6scher","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2026.10.005_bib0013","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.seizure.2017.06.022","article-title":"Outside the box: medications worth considering when traditional antiepileptic drugs have failed","volume":"50","author":"Turner","year":"2017","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2026.10.005_bib0014","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for reporting literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.seizure.2026.10.005_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.seizure.2026.10.005_bib0016","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2026.10.005_bib0017","first-page":"771","article-title":"Observations on the metabolic and clinical effects of carbonic anhydrase inhibitors","volume":"84","author":"Bergstr\u00f6m","year":"1952","journal-title":"Am J Dis Child"},{"issue":"12","key":"10.1016\/j.seizure.2026.10.005_bib0018","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.4.11.863","article-title":"Diamox: a carbonic anhydrase inhibitor; its use in epilepsy","volume":"4","author":"Merlis","year":"1954","journal-title":"Neurology"},{"issue":"4968","key":"10.1016\/j.seizure.2026.10.005_bib0019","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/bmj.1.4968.650","article-title":"Acetazolamide in treatment of epilepsy","volume":"1","author":"Ansell","year":"1956","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.seizure.2026.10.005_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1542\/peds.17.4.541","article-title":"Ineffectiveness of diamox in the treatment of childhood epilepsy","volume":"17","author":"Livingston","year":"1956","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.seizure.2026.10.005_bib0021","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jama.1956.02960390018006","article-title":"Further evaluation of acetazolamide (Diamox) in treatment of epilepsy","volume":"160","author":"Lombroso","year":"1956","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.seizure.2026.10.005_bib0022","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.6.8.552","article-title":"Anticonvulsant action of Diamox in children","volume":"6","author":"Millichap","year":"1956","journal-title":"Neurology"},{"issue":"430","key":"10.1016\/j.seizure.2026.10.005_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1192\/bjp.103.430.214","article-title":"Control of petit mal by acetazolamide","volume":"103","author":"Golla","year":"1957","journal-title":"J Ment Sci"},{"issue":"23","key":"10.1016\/j.seizure.2026.10.005_bib0024","first-page":"564","article-title":"Acetazolamide (Diamox) in the treatment of epilepsy","volume":"31","author":"Minde","year":"1957","journal-title":"S Afr Med J"},{"key":"10.1016\/j.seizure.2026.10.005_bib0025","first-page":"110","article-title":"Diamox acetazolamide in treatment of epilepsy","volume":"18","author":"Wada","year":"1957","journal-title":"Dis Nerv Syst"},{"issue":"2","key":"10.1016\/j.seizure.2026.10.005_bib0026","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-3476(58)80168-7","article-title":"A clinical evaluation of acetazolamide (Diamox) in the treatment of epilepsy in children","volume":"53","author":"Holowach","year":"1958","journal-title":"J Pediatr"},{"issue":"7060","key":"10.1016\/j.seizure.2026.10.005_bib0027","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0140-6736(58)90578-6","article-title":"ACZ therapy in epilepsy","volume":"272","author":"Ross","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2026.10.005_bib0028","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1528-1157.1959.tb04283.x","article-title":"A long-term follow-up of acetazolamide (Diamox) in the treatment of epilepsy","volume":"1","author":"Lombroso","year":"1959","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.10.005_bib0029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3476(61)80160-1","article-title":"Diamox in epilepsy: a critical review of 178 cases","volume":"58","author":"Chao","year":"1961","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.seizure.2026.10.005_bib0030","first-page":"98","article-title":"Diamox acetazolamide in treatment of the epileptics with frequent seizures or status epilepticus","volume":"15","author":"Wada","year":"1961","journal-title":"Folia Psychiatr Neurol Jpn"},{"issue":"6","key":"10.1016\/j.seizure.2026.10.005_bib0031","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1469-8749.1981.tb02064.x","article-title":"Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children","volume":"23","author":"Forsythe","year":"1981","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2026.10.005_bib0032","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1528-1157.1989.tb05285.x","article-title":"Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures","volume":"30","author":"Oles","year":"1989","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2026.10.005_bib0033","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1212\/WNL.40.11.1677","article-title":"Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy","volume":"40","author":"Jr","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.10.005_bib0034","first-page":"29","article-title":"Role of acetazolamide in the treatment of partial epilepsy","volume":"3","author":"Iype","year":"2000","journal-title":"Ann Indian Acad Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2026.10.005_bib0035","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1528-1157.2001.33600.x","article-title":"Acetazolamide in women with catamenial epilepsy","volume":"42","author":"Lim","year":"2001","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2026.10.005_bib0036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0387-7604(02)00003-7","article-title":"Long-term effectiveness and side effects of ACZ as an adjunct to other anticonvulsants in the treatment of refractory epilepsies","volume":"24","author":"Katayama","year":"2002","journal-title":"Brain Dev"},{"issue":"9","key":"10.1016\/j.seizure.2026.10.005_bib0037","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1111\/epi.13101","article-title":"Acetazolamide for electrical status epilepticus in slow-wave sleep","volume":"56","author":"Fine","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.10.005_bib0038","article-title":"CACNA1A-associated epilepsy: electroclinical findings and treatment response on seizures in 18 patients","volume":"172","author":"Le Roux","year":"2021","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.seizure.2026.10.005_bib0039","doi-asserted-by":"crossref","first-page":"674","DOI":"10.51253\/pafmj.v73i3.6538","article-title":"Efficacy of ACZ in refractory epilepsy management: a quasi-experimental study","volume":"73","author":"Zamir","year":"2023","journal-title":"Pak Armed Forces Med J"},{"issue":"9","key":"10.1016\/j.seizure.2026.10.005_bib0040","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1111\/epi.17684","article-title":"A concise study of acetazolamide in glucose transporter type 1 deficiency (G1D) epilepsy","volume":"64","author":"M\u00e1laga","year":"2023","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.10.005_bib0041","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/epi4.13034","article-title":"Effectiveness of add-on ACZ in children with drug-resistant CHD2-related epilepsy and in a zebrafish CHD2 model","volume":"9","author":"Melikishvili","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2026.10.005_bib0042","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/epi4.70155","article-title":"Adjunctive acetazolamide for drug-resistant seizures in SLC6A1-related neurodevelopmental disorder: an exploratory case series","volume":"10","author":"Melikishvili","year":"2025","journal-title":"Epilepsia Open"},{"issue":"2","key":"10.1016\/j.seizure.2026.10.005_bib0043","article-title":"Acetazolamide-responsive autoimmune epilepsy with pilomotor seizures","volume":"10","author":"Gilani","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.seizure.2026.10.005_bib0044","first-page":"21","article-title":"Unexpected control of epilepsy in Sturge-Weber syndrome with acetazolamide","volume":"45","author":"Lyall","year":"2008","journal-title":"Clin Exp Neurol"},{"key":"10.1016\/j.seizure.2026.10.005_bib0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.seizure.2021.06.029","article-title":"SLC13A5-related epileptic encephalopathy successfully treated with valproate and acetazolamide","volume":"91","author":"Pellegrino","year":"2021","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2026.10.005_bib0046","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.seizure.2012.12.003","article-title":"A case of atypical benign partial epilepsy with action myoclonus","volume":"22","author":"Kobayashi","year":"2013","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.seizure.2026.10.005_bib0047","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1046\/j.1528-1157.2003.53002.x","article-title":"Acetazolamide and autosomal dominant nocturnal frontal lobe epilepsy","volume":"44","author":"Varadkar","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.10.005_bib0048","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.seizure.2023.06.013","article-title":"Acetazolamide responsive early-onset absence epilepsy and ataxia in a toddler with a KCNA2 genetic variant: a case report","volume":"110","author":"Balaram","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2026.10.005_bib0049","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.seizure.2025.07.016","article-title":"Acetazolamide as a solution in pharmacoresistant epilepsy with eyelid myoclonia (Jeavons syndrome)","volume":"131","author":"Roga\u010d","year":"2025","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.seizure.2026.10.005_bib0050","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1528-1157.2002.11302.x","article-title":"Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet","volume":"43","author":"Kossoff","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.10.005_bib0051","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yebeh.2017.05.032","article-title":"An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy","volume":"74","author":"Yuen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2026.10.005_bib0052","article-title":"Concomitant use of carbonic anhydrase inhibitors and risk of acidosis","year":"2025","journal-title":"RELIS Drug Information Database"},{"issue":"6","key":"10.1016\/j.seizure.2026.10.005_bib0053","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/epi.12125","article-title":"Risk factors for hyperammonemia in pediatric patients with epilepsy","volume":"54","author":"Yamamoto","year":"2013","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2026.10.005_bib0054","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng","year":"2014","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.seizure.2026.10.005_bib0055","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2291336","article-title":"Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship","volume":"39","author":"Tsikas","year":"2024","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"10.1016\/j.seizure.2026.10.005_bib0056","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1528-1157.1989.tb05456.x","article-title":"Mechanisms of tolerance to the anticonvulsant effects of acetazolamide in mice: relation to the activity and amount of carbonic anhydrase in brain","volume":"30","author":"Anderson","year":"1989","journal-title":"Epilepsia"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126003055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126003055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:28:01Z","timestamp":1792222081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":56,"alternative-id":["S1059131126003055"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.10.005","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetazolamide in drug-resistant epilepsy: a systematic review with meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}